Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | HPGD | P15428 | 5/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | TOP2A | P11388 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 7/20 | 0.46 |
| ▸ | RAB9A | P51151 | 5/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 5/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | PKM | P14618 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13620963 | 0.93 | ALDH1A1 (0.54) | ALDH1A1HPGDKDM4EMAPTUSP2 | |
| SCHEMBL13620962 | 0.91 | ALDH1A1 (0.55) | ALDH1A1HPGDKDM4EMAPTUSP2 | |
| SCHEMBL13620983 | 0.90 | NPC1 (0.54) | ALDH1A1HPGDKDM4EMAPTUSP2 | |
| SCHEMBL13620973 | 0.87 | ALDH1A1 (0.55) | ALDH1A1HPGDKDM4EMAPTUSP2 | |
| SCHEMBL22205293 | 0.86 | NPC1 (0.54) | ALDH1A1HPGDKDM4EMAPTUSP2 | |
| SCHEMBL1925604 | 0.86 | NPC1 (0.63) | ALDH1A1HPGDKDM4EMAPTUSP2 | |
| SCHEMBL13620965 | 0.85 | KDM4E (0.59) | ALDH1A1HPGDKDM4EMAPTUSP2 | |
| SCHEMBL4360878 | 0.84 | NPC1 (0.61) | ALDH1A1HPGDKDM4EMAPTUSP2 | |
| SCHEMBL13620964 | 0.84 | NPC1 (0.61) | ALDH1A1HPGDKDM4EMAPTUSP2 | |
| SCHEMBL13620975 | 0.84 | ALDH1A1 (0.50) | ALDH1A1HPGDKDM4EMAPTUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8859108-B2 | Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-10-14 | — | — | US | disclosed |
| US-8859108-B2 | Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-10-14 | — | — | US | disclosed |
| US-20090286985-A1 | Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same | SEMICONDUCTOR ENERGY LABARATORY CO., LTD. | 2009-11-19 | — | — | US | disclosed |
| US-20090286985-A1 | Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same | SEMICONDUCTOR ENERGY LABARATORY CO., LTD. | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286985-A1 | Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same | CYP4X1, XDH, GABRA5 | ALDH1A1 169/4885HPGD 700/4885KDM4E 2877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.